Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease.
about
Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse modelsMechanobiology of myofibroblast adhesion in fibrotic cardiac diseaseIn vitro models of aortic valve calcification: solidifying a systemMolecular and cellular aspects of calcific aortic valve diseaseMyofibroblasts: trust your heart and let fate decide.The heterogeneous biomechanics and mechanobiology of the mitral valve: implications for tissue engineering.Cardiac fibroblast: the renaissance cell.Calcific aortic valve stenosis: methods, models, and mechanismsElectrospun PGS:PCL microfibers align human valvular interstitial cells and provide tunable scaffold anisotropyRoles of transforming growth factor-β1 and OB-cadherin in porcine cardiac valve myofibroblast differentiation.Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves.Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells.Engineering complex tissues.The role of valvular endothelial cell paracrine signaling and matrix elasticity on valvular interstitial cell activation.Embryonic Development of the Bicuspid Aortic Valve.Boundary stiffness regulates fibroblast behavior in collagen gels.In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.TGF-β mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve diseasePeriostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents.Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction.Drug-induced valvulopathy: an update.Serotonin receptors and heart valve disease--it was meant 2B.Mitral valvular interstitial cell responses to substrate stiffness depend on age and anatomic region.Anisotropic poly(ethylene glycol)/polycaprolactone hydrogel-fiber composites for heart valve tissue engineering.Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus.Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves.Potential drug targets for calcific aortic valve disease.Characterization of porcine aortic valvular interstitial cell 'calcified' nodulesRole of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation.Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform.Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves.Insights into aortic sclerosis and its relationship with coronary artery diseaseDefining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease.Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly.Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.Myocardin-related transcription factors A and B are key regulators of TGF-β1-induced fibroblast to myofibroblast differentiation.Design and validation of a novel splashing bioreactor system for use in mitral valve organ culture.Interstitial fluid flow and cyclic strain differentially regulate cardiac fibroblast activation via AT1R and TGF-β1.Transforming growth factor beta signaling in adult cardiovascular diseases and repair.
P2860
Q26994661-B3A28468-B008-4B11-8EAB-DABC6946A03BQ27011753-624E870E-4A3F-4CDB-8122-EDF034B2C4E6Q27022156-C50EF00B-1FB1-4FC3-992E-750CC8D21132Q27026105-82046432-7269-4C5E-9A2A-0094A33793D2Q27692541-E07D324F-8981-41EA-A044-01981C6AEE1BQ30413608-300B620D-4D0A-4C70-8B32-CA631D5FD7C3Q30467800-331C459F-1074-476C-BA22-DE0634A239B0Q30503246-25B4E8FB-A08D-4C5B-9A1F-36FB68A4C49EQ30580483-5066B9F5-749D-4391-B0F3-8D37361DC288Q30594252-BCDC9197-6584-4DEA-98A3-7701833D97ABQ33319074-F9883585-7931-4E14-8EF5-351B7121CEDCQ33605863-BB07DEF2-5F92-4482-8464-8EF546D8C03BQ33650172-472550C5-632F-42D9-8BBB-A3488485710CQ33692958-CF858BC2-CB9E-4FF1-816E-EF6A2D043456Q33708015-F401D50B-7AAC-498C-A5B2-B97E5B44DF91Q33739350-194E94CB-24CA-4E28-8CFB-D3801B1BF235Q33765102-6B27AEC9-600E-496A-A516-397C05043884Q33935634-B11E18C7-69F0-4715-B99B-05F454B5B8DDQ33968020-130477F6-3A81-4B1D-97FA-A8FB01EE7685Q34066752-BCB061CC-1E61-451F-96B0-F9301F9FE984Q34131760-1B235733-9648-4C26-BB20-7876296DC605Q34173511-0C797A41-ACE5-408E-AA53-5B209F8DD465Q34258618-B9BFE2E9-952F-460E-B771-34E48E176BE5Q34331341-1E6BF631-2E7E-4F9D-A488-1F7832759955Q34341710-EB238409-7979-4E26-BAF2-37C4A5D05340Q34374246-99047770-33B2-4F6F-BC8B-543C5663E388Q34399089-A2EB1567-4B16-4EDD-9068-439A757F3611Q34460998-DD1F2B2A-DCF2-4C43-8B00-AF01EBD71D81Q34600308-82D119E0-FB0A-4339-A217-F9D764816A55Q34772618-F6AAAD99-FF91-4E69-9169-8E8C818C1260Q34920768-09C74BED-F095-4616-872D-1C8D6F73FE8EQ35070613-7B53D2BB-E88E-4C05-87DE-FBBD18BAD282Q35078393-66382142-439D-4A6E-AA1B-CDDCE64B2EF0Q35113410-30437E66-738B-4A5F-AF3E-01566499685FQ35116249-06B638C4-C833-4D10-A7BD-3322A4F78350Q35137484-9FE82E97-C74E-45E8-8B1B-09D44FAB9084Q35417672-DEE68787-3618-49EF-B58A-3769644474F2Q35547713-4EAEAF9C-4485-4E3A-BA05-820711A34062Q35566740-C8B635E2-2CBE-4132-BA10-77F523B3CCB8Q35895390-A7BCAFF4-D5D6-4991-814E-2E210B5B283D
P2860
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Valvular myofibroblast activat ...... deling in heart valve disease.
@en
Valvular myofibroblast activat ...... deling in heart valve disease.
@nl
type
label
Valvular myofibroblast activat ...... deling in heart valve disease.
@en
Valvular myofibroblast activat ...... deling in heart valve disease.
@nl
prefLabel
Valvular myofibroblast activat ...... deling in heart valve disease.
@en
Valvular myofibroblast activat ...... deling in heart valve disease.
@nl
P2093
P1433
P1476
Valvular myofibroblast activat ...... odeling in heart valve disease
@en
P2093
Darshita N Shah
Gennyne A Walker
Kristi S Anseth
Kristyn S Masters
P304
P356
10.1161/01.RES.0000136520.07995.AA
P577
2004-06-24T00:00:00Z